Rapid Diagnostic Kits Market, Global Outlook and Forecast 2023-2028

Report ID: 1633001 | Published Date: Jan 2025 | No. of Page: 60 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story

The rapid diagnostic kits are used to detect or diagnose a variety of infections, diseases, and illnesses that a patient may have. In addition, these kits can accurately diagnose diseases such as malaria, as well as diseases such as diabetes and pregnancy.
This report contains market size and forecasts of Rapid Diagnostic Kits in Global, including the following market information:
Global Rapid Diagnostic Kits Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rapid Diagnostic Kits market was valued at 18220 million in 2021 and is projected to reach US$ 24480 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lateral Flow Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rapid Diagnostic Kits include Abbott Laboratories, Alfa Scientific Designs, Artron Laboratories, BD, Meridian Bioscience, ACON Laboratories, Creative Diagnostics, BTNX and McKesson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rapid Diagnostic Kits companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rapid Diagnostic Kits Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rapid Diagnostic Kits Market Segment Percentages, by Type, 2021 (%)
Lateral Flow Test
Agglutination Assays
Flow Through
Solid Phase
Global Rapid Diagnostic Kits Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rapid Diagnostic Kits Market Segment Percentages, by Application, 2021 (%)
Hospitals and Clinical Testing
Home Testing
Veterinary Testing
Other
Global Rapid Diagnostic Kits Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rapid Diagnostic Kits Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rapid Diagnostic Kits revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rapid Diagnostic Kits revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Alfa Scientific Designs
Artron Laboratories
BD
Meridian Bioscience
ACON Laboratories
Creative Diagnostics
BTNX
McKesson
Roche
Zoetis
BioMerieux

Frequently Asked Questions
Rapid Diagnostic Kits Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rapid Diagnostic Kits Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rapid Diagnostic Kits Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports